 |
인쇄하기
취소
|
SK Launches Anticoagulant Agent in Domestic Market
SK Chemical and SK Pharma announced an official launching of Futhan inj. (active ingredient: nafamostat mesilate), a potent protease inhibitor originally developed by Torii Pharmaceutical of Japan, in the domestic market starting February 1st.
After obtaining a domestic marketing approval by the Korea Food and Drug Administration (KFDA) in June of last year, Futhan inj. has since been regist...
After obtaining a domestic marketing approval by the Korea Food and Drug Administration (KFDA) in June of last year, Futhan inj. has since been regist...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.